amoxapine has been researched along with Weight Gain in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Weight Gain: Increase in BODY WEIGHT over existing weight.
Excerpt | Relevance | Reference |
---|---|---|
"Amoxapine was associated with less EPS and less prolactin elevation than risperidone." | 2.71 | Amoxapine as an atypical antipsychotic: a comparative study vs risperidone. ( Apiquian, R; de la Fuente-Sandoval, C; Fresan, A; Herrera-Estrella, M; Kapur, S; Nicolini, H; Ulloa, RE; Vazquez, A, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apiquian, R | 1 |
Fresan, A | 1 |
Ulloa, RE | 1 |
de la Fuente-Sandoval, C | 1 |
Herrera-Estrella, M | 1 |
Vazquez, A | 1 |
Nicolini, H | 1 |
Kapur, S | 1 |
1 trial available for amoxapine and Weight Gain
Article | Year |
---|---|
Amoxapine as an atypical antipsychotic: a comparative study vs risperidone.
Topics: Adolescent; Adult; Amoxapine; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind M | 2005 |